LBI-HTA - Publications - Search - [Targeted radionuclide therapy with 90Y- and 177-Lu-DOTATOC in patients with neuroendocrine tumors. HTA in hospitals]

Adlbrecht, C. and Wild, C. (2007): [Targeted radionuclide therapy with 90Y- and 177-Lu-DOTATOC in patients with neuroendocrine tumors. HTA in hospitals]. Decision Support Document 02.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
385Kb

Item Type:Decision Support Document
Keywords:Radionuclide therapy, gastrointestinal tract, gastro-entero-pancreatic neuroendocrine tumours/ tumors (NETs), Zollinger-Ellison tumor/tumour, gastrinoma, vipoma, carcinoid syndrome, palliative care, octreotide, Sandostatin
Subjects:WK Endocrine system > WK 800-920 Islets of Langerhans and gonads
WK Endocrine system > WK 500-590 Pituitary gland
WB Practice of medicine > WB 300-962 Therapeutics > WB 310 Palliative care
WI Digestive system > WI 400-560 Intestines
Related URLs:http://hta.lbg.ac.at/en/content.php?iMenuID=40
Language:German
Series Name:Decision Support Document
Number:02
Deposited on:14 Jan 2008 21:19
Last Modified:18 Jan 2008 19:09

Repository Staff Only: item control page